BE in orodispersible tablets [Design Issues]

posted by ElMaestro  – Denmark, 2011-04-11 12:24 (5555 d 02:34 ago) – Posting: # 6885
Views: 4,474

Dear Dr_Dan,

page 22 of the holy scripture provides guidance.
Apart from blahblah the most important sentence in my opinion is "Bioequivalence studies should be conducted according to the recommended use of the product."

If the vols have never used such formulations before or are study-naïve they may be a bit nervous in the first period (or at least more nervous in the first than in the second). This may cause dry mouth in the first period but less so in the next etc, and can affect disperison time and thus add spurious variation. To minimise variation a bit of training therefore could be relevant.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
275 visitors (0 registered, 275 guests [including 22 identified bots]).
Forum time: 14:58 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5